Starbucks earnings missed by $0.15, revenue topped estimates

Starbucks (NASDAQ: SBUX) reported mixed third-quarter results, with EPS of $0.50 significantly missing the $0.65 analyst estimate, while revenue of $9.5 billion surpassed the $9.29 billion consensus. This profitability miss occurred despite 27 negative EPS revisions in the preceding 90 days, with the company's financial health rated as 'fair performance'.

Analysis

Starbucks (SBUX) delivered mixed third-quarter results, revealing a significant disconnect between top-line performance and profitability. The company surpassed revenue consensus with $9.5 billion versus an expected $9.29 billion, but reported earnings per share of $0.50, a substantial $0.15 miss against the $0.65 analyst estimate. This profitability shortfall is particularly concerning as it occurred despite a backdrop of already lowered expectations, evidenced by 27 negative EPS revisions in the 90 days prior to the announcement. The company's financial health score is categorized as merely "fair performance," suggesting underlying margin pressures or operational challenges are weighing on its bottom line. In a separate, unrelated headline development, Novo Nordisk (NVO) reportedly cut its full-year guidance, an event associated with a highly negative sentiment signal (-0.8) for the stock.

Key Decisions for Investors

• Investors should prioritize understanding the drivers behind Starbucks' significant EPS miss, as the sharp deviation from estimates, even after numerous downward revisions, signals potential margin deterioration that overshadows the revenue beat.
• Given the 'fair' financial health rating and the negative earnings surprise, it would be prudent to re-evaluate forward earnings models for SBUX and monitor for further signs of fundamental weakness before adding to positions, despite the stock's strong trailing 12-month performance.
• For investors with exposure to Novo Nordisk, the report of a guidance cut is a material event that warrants immediate confirmation and an assessment of its impact on the stock's valuation and outlook.